we have bernd montag joining us.ood morning let's start with the performance for the quarter above market he can pecexpectations >> we are happy with the start into the fiscal year with the strong revenue growth of 7% or so in addition to the very, very good order intake. i'm, as you said, particularly happy about the 22% growth which shows our strong position in cancer care, but also underlines the strength of the combination of our imaging franchise and cancer care treatment. >> in prior quarters, you flagged supply chain issues with respect to what pertains to china and the geographic presence within china. how is that looking now? would you say most of the supply chain issues have been resolved or are you concerned new supply chain issues could pop up with the disruption in the red sea right now? >> let me correct a little bit this has been a situation we had with one of our core suppliers which was relocating for different reasons his production from china to mexico and then the yield of that new factory was not